No.,Title,Link
1,Cancer cell reprogramming: a promising therapy converting malignancy to benignity,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0393-5
2,Radiation pneumonitis complicated by Pneumocystis carinii in patients with thoracic neoplasia: a clinical analysis of 7 cases,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0392-6
3,"Effects of two types of exercise training on psychological well-being, sleep, quality of life and physical fitness in patients with high-grade glioma (WHO III and IV): study protocol for a randomized controlled trial",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0390-8
4,Complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases: results of a propensity score matching analysis from France,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0391-7
5,Clinical outcomes of angiosarcoma: a single institution experience,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0389-1
6,Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectives,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0387-3
7,Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0388-2
8,Regulation of CD137 expression through K-Ras signaling in pancreatic cancer cells,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0386-4
9,Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0380-x
10,Induction gemcitabine and cisplatin in locoregionally advanced nasopharyngeal carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0385-5
11,Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trial,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0384-6
12,Somatic mutations in renal cell carcinomas from Chinese patients revealed by targeted gene panel sequencing and their associations with prognosis and PD-L1 expression,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0382-8
13,China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non-small cell lung cancer after two lines of chemotherapy,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0383-7
14,Microscopic tumor foci in axillary lymph nodes may reveal the recurrence dynamics of breast cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0381-9
15,Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cells,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0379-3
16,Preferable background filtering for next-generation sequencing analysis in non-small cell lung cancer: pericarcinomatous tissues or peripheral blood lymphocytes?,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0378-4
17,A homogenized approach to classify advanced gastric cancer patients with limited and adequate number of pathologically examined lymph nodes,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0370-z
18,Modelling the probability of erroneous negative lymph node staging in patients with colon cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0377-5
19,PD-L1 and PD-L2 expression correlated genes in non-small-cell lung cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0376-6
20,"Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11)",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0375-7
21,"CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0374-8
22,Is cancer-related death associated with circadian rhythm?,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0373-9
23,The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreatic cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0367-7
24,Is surgical axillary staging necessary in women with T1 breast cancer who are treated with breast-conserving therapy?,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0371-y
25,National trend of gastric cancer mortality in China (2003–2015): a population-based study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0372-x
26,Dual prognostic role of 2-oxoglutarate-dependent oxygenases in ten cancer types: implications for cell cycle regulation and cell adhesion maintenance,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0369-5
27,Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0368-6
28,Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0365-9
29,Molecular analysis of cell-free DNA identifies distinct molecular features in patients with chemosensitive and chemorefractory small cell lung cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0363-y
30,An improved ileal conduit surgery for bladder cancer with fewer complications,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0366-8
31,Target delineation and dose prescription of adaptive replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0364-x
32,Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0362-z
33,"Irinotecan plus S-1 versus S-1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open-labeled phase 3 trial",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0359-7
34,Primary intrathoracic liposarcoma: a clinical analysis of 31 cases,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0358-8
35,The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0357-9
36,Mucinous colorectal adenocarcinoma: clinical pathology and treatment options,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0361-0
37,Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0356-x
38,Recent trends from the results of clinical trials on gastric cancer surgery,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0360-1
39,The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0349-9
40,Disrupting redox stabilizer: a novel therapeutic strategy for colorectal cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0355-y
41,Skull bone tumor: a review of clinicopathological and neuroimaging characteristics of 426 cases at a single center,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0353-0
42,Identification of genetic alterations associated with primary resistance to EGFR-TKIs in advanced non-small-cell lung cancer patients with EGFR sensitive mutations,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0354-z
43,"Correction to: Incidence, mortality, and temporal patterns of oropharyngeal cancer in China: a population-based study",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0352-1
44,Carbon ion radiotherapy boost in the treatment of glioblastoma: a randomized phase I/III clinical trial,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0351-2
45,Clinicopathological features and impact of adjuvant chemotherapy on the long-term survival of patients with multiple gastric cancers: a propensity score matching analysis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0350-3
46,TES functions as a Mena-dependent tumor suppressor in gastric cancer carcinogenesis and metastasis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0347-y
47,A novel role of LncRNA in regulating tumor metabolism and angiogenesis under hypoxia,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0348-x
48,The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial–mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0346-4
49,"Incidence, mortality, and temporal patterns of oropharyngeal cancer in China: a population-based study",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0345-5
50,A curative-intent endoscopic surgery for postradiation nasopharyngeal necrosis in patients with nasopharyngeal carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0338-4
51,Cancer cell reprogramming: a promising therapy converting malignancy to benignity,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0393-5
52,Radiation pneumonitis complicated by Pneumocystis carinii in patients with thoracic neoplasia: a clinical analysis of 7 cases,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0392-6
53,"Effects of two types of exercise training on psychological well-being, sleep, quality of life and physical fitness in patients with high-grade glioma (WHO III and IV): study protocol for a randomized controlled trial",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0390-8
54,Complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases: results of a propensity score matching analysis from France,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0391-7
55,Clinical outcomes of angiosarcoma: a single institution experience,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0389-1
56,Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectives,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0387-3
57,Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0388-2
58,Regulation of CD137 expression through K-Ras signaling in pancreatic cancer cells,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0386-4
59,Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0380-x
60,Induction gemcitabine and cisplatin in locoregionally advanced nasopharyngeal carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0385-5
61,Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trial,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0384-6
62,Somatic mutations in renal cell carcinomas from Chinese patients revealed by targeted gene panel sequencing and their associations with prognosis and PD-L1 expression,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0382-8
63,China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non-small cell lung cancer after two lines of chemotherapy,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0383-7
64,Microscopic tumor foci in axillary lymph nodes may reveal the recurrence dynamics of breast cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0381-9
65,Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cells,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0379-3
66,Preferable background filtering for next-generation sequencing analysis in non-small cell lung cancer: pericarcinomatous tissues or peripheral blood lymphocytes?,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0378-4
67,A homogenized approach to classify advanced gastric cancer patients with limited and adequate number of pathologically examined lymph nodes,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0370-z
68,Modelling the probability of erroneous negative lymph node staging in patients with colon cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0377-5
69,PD-L1 and PD-L2 expression correlated genes in non-small-cell lung cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0376-6
70,"Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11)",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0375-7
71,"CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0374-8
72,Is cancer-related death associated with circadian rhythm?,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0373-9
73,The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreatic cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0367-7
74,Is surgical axillary staging necessary in women with T1 breast cancer who are treated with breast-conserving therapy?,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0371-y
75,National trend of gastric cancer mortality in China (2003–2015): a population-based study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0372-x
76,Dual prognostic role of 2-oxoglutarate-dependent oxygenases in ten cancer types: implications for cell cycle regulation and cell adhesion maintenance,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0369-5
77,Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0368-6
78,Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0365-9
79,Molecular analysis of cell-free DNA identifies distinct molecular features in patients with chemosensitive and chemorefractory small cell lung cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0363-y
80,An improved ileal conduit surgery for bladder cancer with fewer complications,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0366-8
81,Target delineation and dose prescription of adaptive replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0364-x
82,Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0362-z
83,"Irinotecan plus S-1 versus S-1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open-labeled phase 3 trial",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0359-7
84,Primary intrathoracic liposarcoma: a clinical analysis of 31 cases,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0358-8
85,The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0357-9
86,Mucinous colorectal adenocarcinoma: clinical pathology and treatment options,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0361-0
87,Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0356-x
88,Recent trends from the results of clinical trials on gastric cancer surgery,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0360-1
89,The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0349-9
90,Disrupting redox stabilizer: a novel therapeutic strategy for colorectal cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0355-y
91,Skull bone tumor: a review of clinicopathological and neuroimaging characteristics of 426 cases at a single center,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0353-0
92,Identification of genetic alterations associated with primary resistance to EGFR-TKIs in advanced non-small-cell lung cancer patients with EGFR sensitive mutations,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0354-z
93,"Correction to: Incidence, mortality, and temporal patterns of oropharyngeal cancer in China: a population-based study",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0352-1
94,Carbon ion radiotherapy boost in the treatment of glioblastoma: a randomized phase I/III clinical trial,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0351-2
95,Clinicopathological features and impact of adjuvant chemotherapy on the long-term survival of patients with multiple gastric cancers: a propensity score matching analysis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0350-3
96,TES functions as a Mena-dependent tumor suppressor in gastric cancer carcinogenesis and metastasis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0347-y
97,A novel role of LncRNA in regulating tumor metabolism and angiogenesis under hypoxia,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-019-0348-x
98,The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial–mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0346-4
99,"Incidence, mortality, and temporal patterns of oropharyngeal cancer in China: a population-based study",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0345-5
100,A curative-intent endoscopic surgery for postradiation nasopharyngeal necrosis in patients with nasopharyngeal carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0338-4
101,"Total mesorectal excision with or without preoperative chemoradiotherapy for resectable mid/low rectal cancer: a long-term analysis of a prospective, single-center, randomized trial",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0342-8
102,Liquid biopsy: a powerful tool to monitor trastuzumab resistance in HER2-positive metastatic gastric cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0344-6
103,The association between early-onset cardiac events caused by neoadjuvant or adjuvant chemotherapy in triple-negative breast cancer patients and some novel autophagy-related polymorphisms in their genomic DNA: a real-world study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0343-7
104,"The genomics of desmoplastic small round cell tumor reveals the deregulation of genes related to DNA damage response, epithelial–mesenchymal transition, and immune response",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0339-3
105,The 150 most important questions in cancer research and clinical oncology series: questions 94–101,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0341-9
106,A modified clinicopathological tumor staging system for survival prediction of patients with penile cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0340-x
107,Proposal and validation of a modified staging system to improve the prognosis predictive performance of the 8th AJCC/UICC pTNM staging system for gastric adenocarcinoma: a multicenter study with external validation,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0337-5
108,"Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open-label, dose-escalation Study",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0330-z
109,Metabolic features of cancer cells,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0335-7
110,"DUXAP8, a pseudogene derived lncRNA, promotes growth of pancreatic carcinoma cells by epigenetically silencing CDKN1A and KLF2",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0333-9
111,Nonmetabolic functions of metabolic enzymes in cancer development,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0336-6
112,IL-2Rα up-regulation is mediated by latent membrane protein 1 and promotes lymphomagenesis and chemotherapy resistance in natural killer/T-cell lymphoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0334-8
113,Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0331-y
114,Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0329-5
115,Development and validation of an endoscopic images-based deep learning model for detection with nasopharyngeal malignancies,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0325-9
116,Snail promotes metastasis of nasopharyngeal carcinoma partly by down-regulating TEL2,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0328-6
117,"Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0327-7
118,Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0326-8
119,External validity of a prognostic nomogram for locoregionally advanced nasopharyngeal carcinoma based on the 8th edition of the AJCC/UICC staging system: a retrospective cohort study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0324-x
120,Personalized treatment based on mini patient-derived xenografts and WES/RNA sequencing in a patient with metastatic duodenal adenocarcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0323-y
121,Overexpression of amplified in breast cancer 1 (AIB1) gene promotes lung adenocarcinoma aggressiveness in vitro and in vivo by upregulating C-X-C motif chemokine receptor 4,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0320-1
122,Tumor vasculature: a sally port for inhibiting cancer cell spreading,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0322-z
123,First-generation EGFR tyrosine kinase inhibitor therapy in 106 patients with compound EGFR-mutated lung cancer: a single institution’s clinical practice experience,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0321-0
124,Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0319-7
125,Lower genomic stability of induced pluripotent stem cells reflects increased non-homologous end joining,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0313-0
126,Guided chemotherapy based on patient-derived mini-xenograft models improves survival of gallbladder carcinoma patients,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0318-8
127,"When fats commit crimes: fatty acid metabolism, cancer stemness and therapeutic resistance",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0317-9
128,Role of (myo)fibroblasts in the development of vascular and connective tissue structure of the C38 colorectal cancer in mice,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0316-x
129,DDIT4 promotes gastric cancer proliferation and tumorigenesis through the p53 and MAPK pathways,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0315-y
130,Interactions between life expectancy and the incidence and mortality rates of cancer in China: a population-based cluster analysis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0308-x
131,Azithromycin enhances anticancer activity of TRAIL by inhibiting autophagy and up-regulating the protein levels of DR4/5 in colon cancer cells in vitro and in vivo,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0309-9
132,Differential incidence trends of colon and rectal cancers in Hong Kong: an age-period-cohort analysis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0311-2
133,Sustained complete response of advanced hepatocellular carcinoma with metronomic capecitabine: a report of three cases,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0312-1
134,Parkinson’s disease-associated protein Parkin: an unusual player in cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0314-z
135,Age exerts a continuous effect in the outcomes of Asian breast cancer patients treated with breast-conserving therapy,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0310-3
136,Boron neutron capture therapy for vulvar melanoma and genital extramammary Paget’s disease with curative responses,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0297-9
137,Clinical trials for treating recurrent head and neck cancer with boron neutron capture therapy using the Tsing-Hua Open Pool Reactor,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0295-y
138,A realistic appraisal of boron neutron capture therapy as a cancer treatment modality,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0280-5
139,Boron delivery agents for neutron capture therapy of cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0299-7
140,Challenges and research opportunities for lung cancer screening in China,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0305-0
141,NS1-binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c-Myc,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0307-y
142,Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0304-1
143,Safety and efficacy of obinutuzumab in Chinese patients with B-cell lymphomas: a secondary analysis of the GERSHWIN trial,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0300-5
144,Spontaneous regression of mantle cell lymphoma: a report of four cases,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0306-z
145,Is there a survival benefit from adjuvant chemotherapy for patients with liver oligometastases from colorectal cancer after curative resection?,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0298-8
146,Epidermal growth factor receptor (EGFR) T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective observational study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0303-2
147,Lipid metabolism reprogramming and its potential targets in cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0301-4
148,Long- versus short-interval follow-up after resection of hepatocellular carcinoma: a retrospective cohort study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0296-x
149,Metabolic recoding of epigenetics in cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0302-3
150,Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0294-z
151,A novel nomogram individually predicting disease-specific survival after D2 gastrectomy for advanced gastric cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0293-0
152,Cardiotoxicity of 5-fluorouracil and capecitabine in Chinese patients: a prospective study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0292-1
153,"Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0283-2
154,Ultrasound-guided fine needle aspiration of retropharyngeal lymph nodes after radiotherapy for nasopharyngeal carcinoma: a novel technique for accurate diagnosis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0286-z
155,Xenograft tumors derived from malignant pleural effusion of the patients with non-small-cell lung cancer as models to explore drug resistance,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0284-1
156,Aldolase A promotes proliferation and G1/S transition via the EGFR/MAPK pathway in non-small cell lung cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0290-3
157,New insights from the widening homogeneity perspective to target intratumor heterogeneity,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0287-y
158,Somatic mutation landscape of a meningioma and its pulmonary metastasis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0291-2
159,Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivo,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0285-0
160,Impact of type 2 diabetes mellitus on short-term and long-term outcomes of patients with esophageal squamous cell cancer undergoing resection: a propensity score analysis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0275-2
161,Integrative analysis of gene expression profiles reveals specific signaling pathways associated with pancreatic duct adenocarcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0289-9
162,Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0288-x
163,"Long-term outcome of a moderately hypofractionated, intensity-modulated radiotherapy approach using an endorectal balloon for patients with localized prostate cancer",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0281-4
164,Nasopharyngeal brushing: a convenient and feasible sampling method for nucleic acid-based nasopharyngeal carcinoma research,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0278-z
165,"Cancer mortality in Serbia, 1991–2015: an age-period-cohort and joinpoint regression analysis",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0282-3
166,Protein-coding genes combined with long noncoding RNA as a novel transcriptome molecular staging model to predict the survival of patients with esophageal squamous cell carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0277-0
167,EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0276-1
168,Decreased macrophage inflammatory protein (MIP)-1α and MIP-1β increase the risk of developing nasopharyngeal carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0279-y
169,Precision medicine becomes reality—tumor type-agnostic therapy,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0274-3
170,Selection of candidates for surgery as local therapy among early-stage small cell lung cancer patients: a population-based analysis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0272-5
171,Long-term outcomes of endoscopic submucosal dissection for high-grade dysplasia and early-stage carcinoma in the colorectum,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0273-4
172,Optimizing the diagnosis of pelvic lymph node metastasis in bladder cancer using computed tomography and magnetic resonance imaging,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0271-6
173,Editorial announcement regarding title change of Chinese Journal of Cancer to Cancer Communications,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0270-7
174,Genetic polymorphisms of autophagy-related gene 5 (ATG5) rs473543 predict different disease-free survivals of triple-negative breast cancer patients receiving anthracycline- and/or taxane-based adjuvant chemotherapy,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0268-1
175,Computed tomography and magnetic resonance imaging evaluation of pelvic lymph node metastasis in bladder cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0269-0
176,Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0267-2
177,The 150 most important questions in cancer research and clinical oncology series: questions 86–93,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-018-0266-3
178,Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein–Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0264-x
179,"Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0263-y
180,Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0260-1
181,Significant value of 18F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0265-9
182,Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0262-z
183,Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0261-0
184,International Szent-Györgyi Prize for Progress in Cancer Research: basic and translational research recognition,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0258-8
185,The 150 most important questions in cancer research and clinical oncology series: questions 76–85,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0259-7
186,"Nasopharyngeal carcinoma incidence and mortality in China, 2013",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0257-9
187,Expression of voltage-gated sodium channel Nav1.5 in non-metastatic colon cancer and its associations with estrogen receptor (ER)-β expression and clinical outcomes,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0253-0
188,Systematic analyses of glutamine and glutamate metabolisms across different cancer types,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0255-y
189,Prognostic value of plasma Epstein–Barr virus DNA level during posttreatment follow-up in the patients with nasopharyngeal carcinoma having undergone intensity-modulated radiotherapy,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0256-x
190,The 150 most important questions in cancer research and clinical oncology series: questions 67–75,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0254-z
191,Conditional survival in patients with gallbladder cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0252-1
192,The influence of stage at diagnosis and molecular subtype on breast cancer patient survival: a hospital-based multi-center study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0250-3
193,Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0251-2
194,Chromatin remodeling factor lymphoid-specific helicase inhibits ferroptosis through lipid metabolic genes in lung cancer progression,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0248-x
195,Clinicopathologic features and treatment efficacy of Chinese patients with BRAF-mutated metastatic colorectal cancer: a retrospective observational study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0247-y
196,The prognostic value of C-X-C motif chemokine receptor 4 in patients with sporadic malignant peripheral nerve sheath tumors,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0246-z
197,The 150 most important questions in cancer research and clinical oncology series: questions 57–66,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0249-9
198,Pathologic response after preoperative therapy predicts prognosis of Chinese colorectal cancer patients with liver metastases,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0244-1
199,Tripartite motif-containing 3 (TRIM3) inhibits tumor growth and metastasis of liver cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0240-5
200,Effects of dosimetric inadequacy on local control and toxicities in the patients with T4 nasopharyngeal carcinoma extending into the intracranial space and treated with intensity-modulated radiotherapy plus chemotherapy,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0245-0
201,Prognostic value of systemic immune-inflammation index in patients with gastric cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0243-2
202,Efficacy and safety of controlled-release oxycodone/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trial,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0241-4
203,Medical expenditure for esophageal cancer in China: a 10-year multicenter retrospective survey (2002–2011),http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0242-3
204,Erythrocytosis caused by giant chromophobe renal cell carcinoma: a case report indicating a 9-year misdiagnosis of polycythemia vera,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0238-z
205,Potential factors associated with clinical stage of nasopharyngeal carcinoma at diagnosis: a case–control study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0239-y
206,Erratum to: Cancer chemoprevention through dietary flavonoids: what’s limiting?,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0237-0
207,The 150 most important questions in cancer research and clinical oncology series: questions 50–56,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0236-1
208,At-home cancer screening: a solution for China and other developing countries with a large population and limited number of healthcare practitioners,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0235-2
209,Awakening immunity against cancer: a 2017 primer for clinicians,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0233-4
210,"Estimates of cancer incidence and mortality in China, 2013",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0234-3
211,Immunohistochemical prognostic markers of esophageal squamous cell carcinoma: a systematic review,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0232-5
212,"Comparison of efficacy, safety, and quality of life between sorafenib and sunitinib as first-line therapy for Chinese patients with metastatic renal cell carcinoma",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0230-7
213,Synthetic lethal short hairpin RNA screening reveals that ring finger protein 183 confers resistance to trametinib in colorectal cancer cells,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0228-1
214,"Prognostic role of ABO blood type in patients with extranodal natural killer/T cell lymphoma, nasal type: a triple-center study",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0229-0
215,"Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0226-3
216,"Spatio-temporal analysis of the incidence of colorectal cancer in Guangzhou, 2010–2014",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0231-6
217,Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0227-2
218,Exploring the potential confounder of nitrogen fertilizers in the relationship between pesticide exposures and risk of leukemia: a Poisson regression with two-way fixed-effects analysis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0225-4
219,Mortality outcomes of low-dose computed tomography screening for lung cancer in urban China: a decision analysis and implications for practice,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0221-8
220,Radiotherapy among nonagenarians with anal or rectal carcinoma: should we avoid or adapt treatment?,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0224-5
221,The 150 most important questions in cancer research and clinical oncology series: questions 40–49,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0222-7
222,Immune evasion might affect survival in laryngeal cancer patients with blood group O,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0223-6
223,Different dissecting orders of the pulmonary bronchus and vessels during right upper lobectomy are associated with surgical feasibility and postoperative recovery for lung cancer patients,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0220-9
224,Autophagy and multidrug resistance in cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0219-2
225,Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0218-3
226,Cancer chemoprevention through dietary flavonoids: what’s limiting?,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0217-4
227,Immunological effect of local ablation combined with immunotherapy on solid malignancies,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0216-5
228,The 150 most important questions in cancer research and clinical oncology series: questions 31–39,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0215-6
229,Association of post-treatment hypoalbuminemia and survival in Chinese patients with metastatic renal cell carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0214-7
230,Long-term outcomes of 307 patients after complete thymoma resection,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0213-8
231,Neuroendocrine carcinoma of the breast: a review of 126 cases in China,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0211-x
232,Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0208-5
233,"CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0212-9
234,The 150 most important questions in cancer research and clinical oncology series: Questions 25–30,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0210-y
235,"Expenditure and financial burden for the diagnosis and treatment of colorectal cancer in China: a hospital-based, multicenter, cross-sectional survey",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0209-4
236,Significance of spatial organization of chromosomes in the progression of acute myeloid leukemia,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0207-6
237,The 150 most important questions in cancer research and clinical oncology series: questions 15–24,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0205-8
238,Cancer metastasis: issues and challenges,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0206-7
239,Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0204-9
240,Tumor microenvironment: driving forces and potential therapeutic targets for breast cancer metastasis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0202-y
241,Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0203-x
242,Progressive multifocal exophytic pontine glioblastoma: a case report with literature review,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0201-z
243,The 150 most important questions in cancer research and clinical oncology series: questions 6–14,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0200-0
244,Clinical treatment considerations in the intensity-modulated radiotherapy era for patients with N0-category nasopharyngeal carcinoma and enlarged neck lymph nodes,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0199-2
245,Left jackknife position: a novel position for laparoscopic hepatectomy,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0190-y
246,The US Chinese Anti-Cancer Association and the Asian Fund for Cancer Research Recognize Young Chinese Cancer Researchers with the 2016 USCACA–AFCR scholar awards,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0197-4
247,Immune mediators in the tumor microenvironment of prostate cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0198-3
248,Corepressor metastasis-associated protein 3 modulates epithelial-to-mesenchymal transition and metastasis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0193-8
249,Weekly taxane–anthracycline combination regimen versus tri-weekly anthracycline-based regimen for the treatment of locally advanced breast cancer: a randomized controlled trial,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0196-5
250,Radiotherapy with neoadjuvant chemotherapy versus concurrent chemoradiotherapy for ascending-type nasopharyngeal carcinoma: a retrospective comparison of toxicity and prognosis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0195-6
251,Ailanthone: a new potential drug for castration-resistant prostate cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0194-7
252,Californium-252 neutron brachytherapy combined with external pelvic radiotherapy plus concurrent chemotherapy for cervical cancer: a retrospective clinical study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0191-x
253,Predictive model for 5-year mortality after breast cancer surgery in Taiwan residents,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0192-9
254,Cell cycle-independent roles of p19INK4d in human terminal erythropoiesis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0189-4
255,Prognostic value of alcohol consumption and some other dietary habits for survival in a cohort of Chinese men with lung cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0188-5
256,Proportion and clinical features of never-smokers with non-small cell lung cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0187-6
257,Id4 promotes cell proliferation in hepatocellular carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0186-7
258,The most important questions in cancer research and clinical oncology—Question 2–5. Obesity-related cancers: more questions than answers,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0185-8
259,Metformin targets multiple signaling pathways in cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0184-9
260,For robust big data analyses: a collection of 150 important pro-metastatic genes,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0178-z
261,Prognostic values of apoptosis-stimulating P53-binding protein 1 and 2 and their relationships with clinical characteristics of esophageal squamous cell carcinoma patients: a retrospective study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0169-0
262,Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0183-x
263,The most important questions in cancer research and clinical oncology,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0168-1
264,Association between DNA mismatch repair gene polymorphisms and platinum-based chemotherapy toxicity in non-small cell lung cancer patients,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0175-2
265,The loss-of-function mutations and down-regulated expression of ASB3 gene promote the growth and metastasis of colorectal cancer cells,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0180-0
266,Is there still a role for cytotoxic chemotherapy after targeted therapy and immunotherapy in metastatic melanoma? A case report and literature review,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0179-6
267,The efficacy of fluoropyrimidine-based adjuvant chemotherapy on biliary tract cancer after R0 resection,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0182-y
268,Concurrent chemoradiotherapy combined with enteral nutrition support: a radical treatment strategy for esophageal squamous cell carcinoma patients with malignant fistulae,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0171-6
269,Effect of body mass index on survival of patients with stage I non-small cell lung cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0170-7
270,"Effect of transcutaneous electrical acupoint stimulation combined with palonosetron on chemotherapy-induced nausea and vomiting: a single-blind, randomized, controlled trial",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0176-1
271,Arresting kinase suppressor of Ras in an inactive state,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-017-0181-z
272,Novel germline mutations in FLCN gene identified in two Chinese patients with Birt–Hogg–Dubé syndrome,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0172-5
273,Associations of lifestyle and diet with the risk of nasopharyngeal carcinoma in Singapore: a case–control study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0174-3
274,Clinical comparison of patients with benign urachal masses versus urachal carcinomas,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0173-4
275,Hydrochloric acid-enhanced radiofrequency ablation for treating a large hepatocellular carcinoma with spontaneous rapture: a case report,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0161-8
276,Defeating cancer: the 150 most important questions in cancer research and clinical oncology,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0165-4
277,Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0167-2
278,"Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab versus FOLFIRI with or without bevacizumab",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0166-3
279,Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0164-5
280,Gemcitabine improves survival in patients with recurrent or metastatic nasopharyngeal carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0163-6
281,Erratum to: Chromatin remodeling factor LSH affects fumarate hydratase as a cancer driver,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0156-5
282,Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0160-9
283,Implications of vessel co-option in sorafenib-resistant hepatocellular carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0162-7
284,Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0159-2
285,The clinical association of programmed cell death protein 4 (PDCD4) with solid tumors and its prognostic significance: a meta-analysis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0158-3
286,Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0157-4
287,Treatment implications of posterior fossa ependymoma subgroups,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0155-6
288,A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0154-7
289,What do oncologists need to know about biosimilar products?,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0151-x
290,ABO blood group is a predictor of survival in patients with laryngeal cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0152-9
291,Radiation-induced osteosarcoma of the maxilla and mandible after radiotherapy for nasopharyngeal carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0153-8
292,Overuse of colorectal cancer screening services in the United States and its implications,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0148-5
293,New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0150-y
294,Phase II open-label study of recombinant circularly permuted TRAIL as a single-agent treatment for relapsed or refractory multiple myeloma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0140-0
295,"Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0145-8
296,What did Sun Yat-sen really die of? A re-assessment of his illness and the cause of his death,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0144-9
297,The journey of personalizing gastric cancer treatment,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0149-4
298,Gastric cancer: current and evolving treatment landscape,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0147-6
299,Combined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0146-7
300,Prognostic factors affecting postoperative survival of patients with solitary small hepatocellular carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0143-x
301,Clinical and molecular characteristics of East Asian patients with von Hippel–Lindau syndrome,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0141-z
302,Subtype distribution and long-term titer fluctuation patterns of serum anti-Epstein–Barr virus antibodies in a non-nasopharyngeal carcinoma population from an endemic area in South China: a cohort study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0130-2
303,Association of microRNA polymorphisms with the risk of head and neck squamous cell carcinoma in a Chinese population: a case–control study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0136-9
304,A comprehensive genomic characterization of esophageal squamous cell carcinoma: from prognostic analysis to in vivo assay,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0142-y
305,Overweight/obese status associates with favorable outcome in patients with metastatic nasopharyngeal carcinoma: a 10-year retrospective study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0139-6
306,Leveraging the power of pooled data for cancer outcomes research,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0132-0
307,"The incidence and mortality of major cancers in China, 2012",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0137-8
308,Chromatin remodeling factor LSH affects fumarate hydratase as a cancer driver,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0138-7
309,Epidemiology of lung cancer and approaches for its prediction: a systematic review and analysis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0135-x
310,EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0133-z
311,Evolution of gastric surgery techniques and outcomes,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0134-y
312,Genetic alteration and mutation profiling of circulating cell-free tumor DNA (cfDNA) for diagnosis and targeted therapy of gastrointestinal stromal tumors,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0131-1
313,The rationale for preventing cancer cachexia: targeting excessive fatty acid oxidation,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0129-8
314,Long-term survival of early-stage non–small cell lung cancer patients who underwent robotic procedure: a propensity score-matched study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0117-z
315,Outcomes of preoperative chemoradiotherapy followed by surgery in patients with unresectable locally advanced sigmoid colon cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0126-y
316,MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0128-9
317,Relapse of both small cell lung cancer and Lambert–Eaton myasthenic syndrome after a 13-year disease-free survival period,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0127-x
318,Low expression of centrosomal protein 78 (CEP78) is associated with poor prognosis of colorectal cancer patients,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0121-3
319,Combination therapy in cancer: effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamics,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0123-1
320,Protein stability regulators screening assay (Pro-SRSA): protein degradation meets the CRISPR–Cas9 library,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0125-z
321,A model to predict the risk of lethal nasopharyngeal necrosis after re-irradiation with intensity-modulated radiotherapy in nasopharyngeal carcinoma patients,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0124-0
322,Palliative primary tumor resection provides survival benefits for the patients with metastatic colorectal cancer and low circulating levels of dehydrogenase and carcinoembryonic antigen,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0120-4
323,Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I–II gastric cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0122-2
324,Chemotherapy in non-small cell lung cancer: opportunities for advancement,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0119-x
325,Colorectal cancer mortality trends in Serbia during 1991–2010: an age-period-cohort analysis and a joinpoint regression analysis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0118-y
326,The expression and prognostic value of protein tyrosine kinase 6 in early-stage cervical squamous cell cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0114-2
327,Molecular profiles to biology and pathways: a systems biology approach,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0112-4
328,"Erratum to: Altered expression of stromal interaction molecule (STIM)-calcium release-activated calcium channel protein (ORAI) and inositol 1,4,5-trisphosphate receptors (IP3Rs) in cancer: will they become a new battlefield for oncotherapy?",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0116-0
329,Whole exome sequencing and single nucleotide polymorphism array analyses to identify germline alterations in genes associated with testosterone metabolism in a patient with androgen insensitivity syndrome and early-onset colorectal cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0115-1
330,Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non–small cell lung cancer cells,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0113-3
331,Emerging molecular classifications and therapeutic implications for gastric cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0111-5
332,The Philadelphia chromosome in leukemogenesis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0108-0
333,Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0109-z
334,Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0110-6
335,Does adding intraperitoneal paclitaxel to standard intraperitoneal regimen yield incremental survival? A propensity score-matched cohort study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0105-3
336,Pediatric spinal glioblastoma of the conus medullaris: a case report of long survival,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0107-1
337,Radiotherapy for gynecologic cancer in nonagenarian patients: a framework for new paradigms,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0104-4
338,Genomic alterations and molecular subtypes of gastric cancers in Asians,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0106-2
339,A new prognostic histopathologic classification of nasopharyngeal carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0103-5
340,"A multicenter, retrospective epidemiologic survey of the clinical features and management of bone metastatic disease in China",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0102-6
341,"Hormonal therapy might be a better choice as maintenance treatment than capecitabine after response to first-line capecitabine-based combination chemotherapy for patients with hormone receptor-positive and HER2-negative, metastatic breast cancer",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0101-7
342,Association of perioperative blood pressure with long-term survival in rectal cancer patients,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0100-8
343,Forty-six cases of nasopharyngeal carcinoma treated with 50 Gy radiotherapy plus hematoporphyrin derivative: 20 years of follow-up and outcomes from the Sun Yat-sen University Cancer Center,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0098-y
344,Cell-free circulating tumor DNA in cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0092-4
345,Prospective study found that peripheral lymph node sampling reduced the false-negative rate of sentinel lymph node biopsy for breast cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0099-x
346,Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0096-0
347,Effect of preoperative injection of carbon nanoparticle suspension on the outcomes of selected patients with mid-low rectal cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0097-z
348,"Altered expression of stromal interaction molecule (STIM)-calcium release-activated calcium channel protein (ORAI) and inositol 1,4,5-trisphosphate receptors (IP3Rs) in cancer: will they become a new battlefield for oncotherapy?",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0094-2
349,Accelerated partial breast irradiation: advances and controversies,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0095-1
350,Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0086-2
351,Chinese Journal of Cancer reviewer acknowledgement 2015,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0090-6
352,Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0089-z
353,"Survival and clinical outcomes in patients with metastatic epidural spinal cord compression after spinal surgery: a prospective, multicenter, observational cohort study",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0091-5
354,Meeting report on the first Sino-Dutch symposium on oncology,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0093-3
355,"Prospective, single-center cohort study analyzing the efficacy of complete laparoscopic resection on recurrent hepatocellular carcinoma",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0088-0
356,Epidemiologic characteristics of oral cancer: single-center analysis of 4097 patients from the Sun Yat-sen University Cancer Center,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0078-2
357,Expert consensus on robotic surgery for colorectal cancer (2015 edition),http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0085-3
358,Twenty years after: the beautiful hypothesis and the ugly facts,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0087-1
359,Future options of anti-angiogenic cancer therapy,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0084-4
360,Long-term outcomes of a phase II randomized controlled trial comparing intensity-modulated radiotherapy with or without weekly cisplatin for the treatment of locally recurrent nasopharyngeal carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0081-7
361,Mechanisms of vascularization in murine models of primary and metastatic tumor growth,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0083-5
362,Why some tumours trigger neovascularisation and others don’t: the story thus far,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0082-6
363,Frederick W. Alt received the 2015 Szent-Györgi Prize for Progress in Cancer Research,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0075-x
364,Co-infection of Epstein-Barr virus and human papillomavirus in human tumorigenesis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0079-1
365,Segmental ureteroileal conduit resection for the treatment of distal upper urinary tract recurrence of bladder cancer following cystectomy,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0077-8
366,Comparisons of biophysical properties and bioactivities of mono-PEGylated endostatin and an endostatin analog,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-016-0080-8
367,Expert consensus on maintenance treatment for metastatic colorectal cancer in China,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0067-x
368,Genomic profiling of lower-grade gliomas uncovers cohesive disease groups: implications for diagnosis and treatment,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0071-1
369,Cumulative scores based on plasma D-dimer and serum albumin levels predict survival in esophageal squamous cell carcinoma patients treated with transthoracic esophagectomy,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0062-2
370,"Revisiting tumor angiogenesis: vessel co-option, vessel remodeling, and cancer cell-derived vasculature formation",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0070-2
371,Carcinogenesis of nasopharyngeal carcinoma: an alternate hypothetical mechanism,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0068-9
372,Phase II study of oxaliplatin combined with S-1 and leucovorin (SOL) for Chinese patients with metastatic colorectal cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0061-3
373,Resectable left lower lobe non–small cell lung cancer with lymph node metastasis is related to unfavorable outcomes,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0069-8
374,Roles of low-density lipoprotein receptor-related protein 1 in tumors,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0064-0
375,Prognostic significance of the pre-chemotherapy lymphocyte-to-monocyte ratio in patients with previously untreated metastatic colorectal cancer receiving FOLFOX chemotherapy,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0063-1
376,Molecular pathogenesis of sporadic colorectal cancers,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0066-y
377,Differentiation therapy: a promising strategy for cancer treatment,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0059-x
378,Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0076-9
379,Occipital lymph node metastasis from nasopharyngeal carcinoma: a special case report and literature review,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0074-y
380,Award for outstanding contributions to the Chinese Journal of Cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0072-0
381,A single nucleotide polymorphism in the Epstein-Barr virus genome is strongly associated with a high risk of nasopharyngeal carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0073-z
382,SHMT1 C1420T polymorphism contributes to the risk of non-Hodgkin lymphoma: evidence from 7309 patients,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0065-z
383,Prognostic values of interim and post-therapy 18F-FDG PET/CT scanning in adult patients with Burkitt’s lymphoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0057-z
384,"Estimation of cancer burden in Guangdong Province, China in 2009",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0060-4
385,Long-term survival trends of gastric cancer patients between 1972 and 2011 in Qidong,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0058-y
386,Incidence and mortality of liver cancer in China in 2011,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0056-0
387,Structural analysis of tumor-related single amino acid mutations in human MxA protein,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0055-1
388,Prognostic role of the ABO blood types in Chinese patients with curatively resected non-small cell lung cancer: a retrospective analysis of 1601 cases at a single cancer center,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0054-2
389,"The updated incidences and mortalities of major cancers in China, 2011",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0042-6
390,"Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin’s lymphoma",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0045-3
391,The prognostic value of Tiam1 protein expression in head and neck squamous cell carcinoma: a retrospective study,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0053-3
392,Wnt3a: functions and implications in cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0052-4
393,Brain metastasis in children with stage 4 neuroblastoma after multidisciplinary treatment,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0038-2
394,A multilevel pan-cancer map links gene mutations to cancer hallmarks,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0050-6
395,Association of insulin-like growth factor-binding protein-3 with radiotherapy response and prognosis of esophageal squamous cell carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0046-2
396,"Stem cell-derived exosomes: roles in stromal remodeling, tumor progression, and cancer immunotherapy",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0051-5
397,The reversal of antineoplastic drug resistance in cancer cells by β-elemene,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0048-0
398,miR-506: a regulator of chemo-sensitivity through suppression of the RAD51-homologous recombination axis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0049-z
399,Targeted therapy: resistance and re-sensitization,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0047-1
400,Cytochrome b5 reductase 2 suppresses tumor formation in nasopharyngeal carcinoma by attenuating angiogenesis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0044-4
401,Clinical parameters predicting pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0033-7
402,Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0031-9
403,The prognostic value of serum C-reactive protein-bound serum amyloid A in early-stage lung cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0039-1
404,Carcinogenic effects of circadian disruption: an epigenetic viewpoint,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0043-5
405,Can radical parametrectomy be omitted in occult cervical cancer after extrafascial hysterectomy?,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0041-7
406,Effects of subsampling on characteristics of RNA-seq data from triple-negative breast cancer patients,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0040-8
407,Clinicopathologic characteristics and therapeutic responses of Chinese patients with non-small cell lung cancer who harbor an anaplastic lymphoma kinase rearrangement,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0032-8
408,"Incidence trends and age distribution of colorectal cancer by subsite in Guangzhou, 2000–2011",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0026-6
409,"Secular trend analysis of lung cancer incidence in Sihui city, China between 1987 and 2011",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0037-3
410,Global efforts in conquering lung cancer in China,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0034-6
411,Targeted therapies for patients with advanced NSCLC harboring wild-type EGFR: what’s new and what’s enough,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0036-4
412,Anti-tumor activities and apoptotic mechanism of ribosome-inactivating proteins,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0030-x
413,Insight into early-phase trials for lung cancer in the United States,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0027-5
414,Early-Phase Oncology Research Training (EFFORT) program: a Hengrui-USCACA joint scholarship,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0035-5
415,Parallel phase 1 clinical trials in the US and in China: accelerating the test of avitinib in lung cancer as a novel inhibitor selectively targeting mutated EGFR and overcoming T790M-induced resistance,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0029-3
416,Predictive biomarkers in precision medicine and drug development against lung cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0028-4
417,Toxic epidermal necrolysis related to AP (pemetrexed plus cisplatin) and gefitinib combination therapy in a patient with metastatic non-small cell lung cancer,http://cancercommun.biomedcentral.com/track/pdf/10.5732/cjc.014.10151
418,Survival analysis of children with stage II testicular malignant germ cell tumors treated with surgery or surgery combined with adjuvant chemotherapy,http://cancercommun.biomedcentral.com/track/pdf/10.5732/cjc.014.10027
419,Optimal follow-up duration for evaluating objective response to radiotherapy in patients with hepatocellular carcinoma: a retrospective study,http://cancercommun.biomedcentral.com/track/pdf/10.5732/cjc.014.10136
420,Use of subsequent PET/CT in diffuse large B-cell lymphoma patients in complete remission following primary therapy,http://cancercommun.biomedcentral.com/track/pdf/10.5732/cjc.014.10124
421,Receptor-type protein tyrosine phosphatases in cancer,http://cancercommun.biomedcentral.com/track/pdf/10.5732/cjc.014.10146
422,Fertility preservation in female cancer patients: a single center experience,http://cancercommun.biomedcentral.com/track/pdf/10.5732/cjc.014.10252
423,Pathobiology of ovarian carcinomas,http://cancercommun.biomedcentral.com/track/pdf/10.5732/cjc.014.10273
424,Trabectedin therapy as an emerging treatment strategy for recurrent platinum-sensitive ovarian cancer,http://cancercommun.biomedcentral.com/track/pdf/10.5732/cjc.014.10278
425,Ovarian cancer: a molecularly insidious disease,http://cancercommun.biomedcentral.com/track/pdf/10.5732/cjc.014.10301
426,"Surgery with versus without preoperative concurrent chemoradiotherapy for mid/low rectal cancer: an interim analysis of a prospective, randomized trial",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0024-8
427,Right- and left-sided colorectal cancers respond differently to cetuximab,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0022-x
428,Elevated peripheral blood lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0025-7
429,Transcatheter arterial chemoembolization combined with CT-guided percutaneous thermal ablation versus hepatectomy in the treatment of hepatocellular carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0023-9
430,Impact of primary tumor volume and location on the prognosis of patients with locally recurrent nasopharyngeal carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0019-5
431,Qualitative visual trichotomous assessment improves the value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in predicting the prognosis of diffuse large B-cell lymphoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0021-y
432,TLR3 gene polymorphisms in cancer: a systematic review and meta-analysis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0020-z
433,Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0015-9
434,Hepatocellular adenoma with malignant transformation in male patients with non-cirrhotic livers,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0014-x
435,Dosimetric benefit to organs at risk following margin reductions in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0016-8
436,"Incidence trend of nasopharyngeal carcinoma from 1987 to 2011 in Sihui County, Guangdong Province, South China: an age-period-cohort analysis",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0018-6
437,Impact of oral anti–hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0017-7
438,"Spatio-temporal analysis of female breast cancer incidence in Shenzhen, 2007–2012",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0013-y
439,Cancer research in the era of next-generation sequencing and big data calls for intelligent modeling,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0008-8
440,The role of interleukin-18 in glioblastoma pathology implies therapeutic potential of two old drugs—disulfiram and ritonavir,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0010-1
441,Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0011-0
442,Metabolic syndrome is associated with better prognosis in patients with tongue squamous cell carcinoma,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0009-7
443,Selective killing of K-ras–transformed pancreatic cancer cells by targeting NAD(P)H oxidase,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0012-z
444,Pharmacogenomics of EGFR-targeted therapies in non–small cell lung cancer: EGFR and beyond,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0007-9
445,Cytokine-induced killer (CIK) cells: from basic research to clinical translation,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0002-1
446,ATP-binding cassette subfamily B member 1 (ABCB1) and subfamily C member 10 (ABCC10) are not primary resistance factors for cabazitaxel,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0003-0
447,Hypertrophic adenoids in patients with nasopharyngeal carcinoma: appearance at magnetic resonance imaging before and after treatment,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0005-y
448,Epithelial cell identity in hyperplastic precursors of breast cancer,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0004-z
449,Association of the Asp312Asn and Lys751Gln polymorphisms in the XPD gene with the risk of non-Hodgkin’s lymphoma: evidence from a meta-analysis,http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0001-2
450,"Pretreatment platelet count improves the prognostic performance of the TNM staging system and aids in planning therapeutic regimens for nasopharyngeal carcinoma: a single-institutional study of 2,626 patients",http://cancercommun.biomedcentral.com/track/pdf/10.1186/s40880-015-0006-x
